Clinical Trials Browser

Phase 2 × Small Cell Lung Carcinoma × abemaciclib × Clear all

NCT04010357 2026-05-12

Targeted Therapy With CDK4/6 Inhibitors in Chemo-Refractory, Rb Wild-Type Extensive SCLC

Phase 2 Completed

Small Cell Lung Carcinoma